Grace Therapeutics, Stock Price on December 3, 2024
| GRCE Stock | 3.99 0.14 3.39% |
Below is the normalized historical share price chart for Grace Therapeutics, extending back to February 07, 2012. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Grace Therapeutics, stands at 3.99, as last reported on the 11th of December 2024, with the highest price reaching 4.46 and the lowest price hitting 3.95 during the day.
If you're considering investing in Grace Stock, it is important to understand the factors that can impact its price. Grace Therapeutics, is very risky given 3 months investment horizon. Grace Therapeutics, holds Efficiency (Sharpe) Ratio of 0.21, which attests that the entity had a 0.21% return per unit of standard deviation over the last 3 months. We were able to break down twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.11% are justified by taking the suggested risk. Use Grace Therapeutics, risk adjusted performance of 0.1333, and Market Risk Adjusted Performance of (3.81) to evaluate company specific risk that cannot be diversified away.
At present, Grace Therapeutics,'s Stock Based Compensation is projected to increase significantly based on the last few years of reporting. The current year's Issuance Of Capital Stock is expected to grow to about 13.4 M, whereas Total Stockholder Equity is forecasted to decline to about 58.7 M. . Grace Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 8th of October 2024 |
Grace |
Sharpe Ratio = 0.2119
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | GRCE | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.26 actual daily | 46 54% of assets are more volatile |
Expected Return
| 1.11 actual daily | 22 78% of assets have higher returns |
Risk-Adjusted Return
| 0.21 actual daily | 16 84% of assets perform better |
Based on monthly moving average Grace Therapeutics, is performing at about 16% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Grace Therapeutics, by adding it to a well-diversified portfolio.
Related Headline
Coca Cola Headline on 3rd of December 2024
Ingalls Snyder LLC Sells 13,395 Shares of The Coca-Cola Comp... by thelincolnianonline.com
Ingalls Snyder LLC reduced its stake in shares of The Coca-Cola Company by 16.5 percent during the 3rd quarter, Holdings Channel.com reports. The firm owned 67,979 shares of the companys stock after selling 13,395 shares during the quarter. Ingalls Snyder LLCs holdings in Coca-Cola were worth 4,885,000 at the end
Grace Therapeutics, Valuation on December 3, 2024
It is possible to determine the worth of Grace Therapeutics, on a given historical date. On December 3, 2024 Grace was worth 3.37 at the beginning of the trading date compared to the closed value of 3.4. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Grace Therapeutics, stock. Still, in general, we apply an absolute valuation method to find Grace Therapeutics,'s value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Grace Therapeutics, where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Grace Therapeutics,'s related companies.
| Open | High | Low | Close | Volume | |
| 3.25 | 3.41 | 3.22 | 3.30 | 142,856 | |
12/03/2024 | 3.37 | 3.45 | 3.23 | 3.40 | 90,229 |
| 3.31 | 4.12 | 3.31 | 4.08 | 176,528 |
| Backtest Grace Therapeutics, | | | Grace Therapeutics, History | | | Grace Therapeutics, Valuation | Previous | Next |
Grace Therapeutics, Trading Date Momentum on December 3, 2024
| On December 04 2024 Grace Therapeutics, was traded for 4.08 at the closing time. The top price for the day was 4.12 and the lowest listed price was 3.31 . The trading volume for the day was 176.5 K. The trading history from December 4, 2024 was a factor to the next trading day price growth. The overall trading delta against the next closing price was 20.00% . The overall trading delta against the current closing price is 21.47% . |
Grace Therapeutics, Fundamentals Correlations and Trends
By evaluating Grace Therapeutics,'s financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Grace Therapeutics,'s main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Grace financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Grace Therapeutics, Stock history
Grace Therapeutics, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Grace is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Grace Therapeutics, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Grace Therapeutics, stock prices may prove useful in developing a viable investing in Grace Therapeutics,
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 9.4 M | 7.9 M |
Grace Therapeutics, Quarterly Net Working Capital |
|
Grace Therapeutics, Stock Technical Analysis
Grace Therapeutics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Grace Therapeutics, Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Grace Therapeutics, cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Grace Therapeutics, December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Grace Therapeutics, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Grace Therapeutics, shares will generate the highest return on investment. By undertsting and applying Grace Therapeutics, stock market strength indicators, traders can identify Grace Therapeutics, entry and exit signals to maximize returns
Grace Therapeutics, Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Grace Therapeutics,'s price direction in advance. Along with the technical and fundamental analysis of Grace Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Grace to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1333 | |||
| Jensen Alpha | 0.935 | |||
| Total Risk Alpha | 0.0652 | |||
| Sortino Ratio | 0.2182 | |||
| Treynor Ratio | (3.82) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Grace Stock analysis
When running Grace Therapeutics,'s price analysis, check to measure Grace Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Grace Therapeutics, is operating at the current time. Most of Grace Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Grace Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Grace Therapeutics,'s price. Additionally, you may evaluate how the addition of Grace Therapeutics, to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |